In vivo > 항암유효성평가지원센터

유효성평가와 기전 규명을 위한 다양한 동물모델을 보유하고 있으며, 이들을 활용하여 임상시험 연계성이 높은 최적의 in vivo 효능 평가 서비스 제공

보유모델

모델

암종

Xenograft

Syngeneic

Subcutaneous 

Bladder

UM-UC-3

Breast

MCF7, MDA-MB-231

4T1, 4T1-Luc-TdTomato

Burkitt’s lymphoma

Raji

Cervix

A431, CaSki

Colon

DLD-1, HCT-8, HCT-15, HCT-116, HT-29, LoVo, RKO, SW620

CT26, MC38

Kidney

SN12C

Leukemia

K562, MV-4-11

Liver

Hep3B, HepG2, Huh7, SK-Hep1

Lung

A549, HCC78, HCC827, NCI-H69, NCI-H209, NCI-H460, NCI-H1299, PC9

LLC1

Melanoma

UACC-62

B16-F10

Ovary

OVCAR-3-Luc

ID8

Pancreas

AsPC-1 (NOG mouse), BxPC-3, MiAPaCa-2

PAN 02

Prostate

DU145, PC3

TRAMP-C1

Stomach

NCI-N87

Orthotopic

Breast

4T1-Luc-TdTomato

Colon

HCT-116-Luc, HT-29-Luc

 

Leukemia

MOLM-13

Lung

A549-Luc

Ovary

ES-2-Luc

ID8-Luc

Pancreas

AsPC-1-Luc, BxPC-3-Luc

Prostate

TRAMP-C1

Metastasis

Breast

4T1-Luc-TdTomato (Intracardiac Injection),

4T1-Luc-TdTomato (Intravenous Injection)

Leukemia

WEHI-3

Ovary

ES-2-Luc (Orthotopic Injection), OVCAR-3-Luc (Intraperitoneal Injection), SK-OV-3-Luc (Intraperitoneal Injection)

Spontaneous Model

Lung

Lung (Mutation: p53/ras)

Genetically Engineered Mouse

Immuno Oncology

CTLA-4 Knock-out Mouse, PD-1 Knock-out Mouse

Lung

Ba/F3/Her2 insertion cell line,
EGFR mutant (L858R+T790M+C797S)-induced lung cancer in mouse

서비스 내용

  • 수요자 맞춤형 시험 디자인
  • Tumor growth inhibition/delay 시험
    • 단독 처리 (single treatment)
    • 병용 처리 (combination treatment)
  • Kaplan-Meier survival 시험
  • Metastasis inhibition 시험
  • Radiotherapy response 시험
  • Histological analysis
    • Tissue preparation, IHC, TUNEL, DNA/RNA/protein extraction 등
    • Histopathology
  • MOA & POC 검증
  • In vivo imaging
    • MRI, PET, PET-MR, CT, Optical imaging 활용 시험
    • PD, tissue distribution

서비스 예시

대장암 subcutaneous xenograft model에서 in vivo 항암 효능 평가